We report disease and cellular process pathways to be mostly enriched from ELD-NL and ELD-AR genes, including “apoptosis”, “hepatitis C”, “p53 signaling pathway”, and “platinum drug resistance”. This evidence concerns the gene TP53 and hepatitis C virus infection.